唾液褪黑素节律与前列腺癌:CAPLIFE研究
CAPLIFE研究分析40例前列腺癌患者与41例对照的唾液褪黑素节律,发现病例组褪黑素水平始终低于对照,平均低64.0%(95%CI -73.4, -51.4)。高振幅与前列腺癌风险降低相关(aOR=0.31,95%CI 0.11, 0.86),晚峰相位可能增加风险(aOR=2.36,95%CI 0.88, 6.27)。
要点
- 前列腺癌患者唾液褪黑素水平始终低于非前列腺癌男性。
- 高褪黑素振幅与前列腺癌风险降低相关(aOR=0.31)。
- 晚峰相位可能增加前列腺癌风险(aOR=2.36),但置信区间跨1。
核心结论
- 前列腺癌患者褪黑素水平始终低于非前列腺癌男性,且不依赖于泌尿症状、肿瘤扩展或侵袭性。
研究设计与样本
- CAPLIFE研究纳入40例前列腺癌病例和41例对照,通过6次唾液样本测定褪黑素节律。
- 振幅和峰相位以对照中位数分类为高/低和早/晚,采用广义估计方程和逻辑回归分析。
主要发现
- 病例组平均褪黑素水平较对照低64.0%(95%CI -73.4, -51.4)。
- 病例组振幅为26.0 pg/ml(SD 27.8),对照组为46.3 pg/ml(SD 28.2),p<0.001。
- 高振幅与前列腺癌风险降低相关,aOR=0.31(95%CI 0.11, 0.86)。
- 晚峰相位与前列腺癌风险升高可能相关,aOR=2.36(95%CI 0.88, 6.27)。
关键数值与推荐
- 振幅 cutoff 采用对照中位数,分为低或高。
- 峰相位 cutoff 采用对照中位数,分为早或晚。
临床怎么用
- 唾液褪黑素节律可能作为前列腺癌风险评估的潜在生物标志物,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We analyzed the association between salivary melatonin rhythm and prostate cancer (PCa). MATERIALS AND METHODS: A total of 40 PCa cases and 41 controls from the CAPLIFE study were analyzed to determine the salivary melatonin rhythm through 6 saliva samples. Amplitude (maximum melatonin peak) was categorized as low or high using the cutoff point median of the controls. Acrophase (time of maximum melatonin peak) was classified as early or late using the same criteria. In addition, the following data were collected: characteristics related to sleep habits, and clinical and sociodemographic information. Melatonin rhythms were represented for cases and controls and analyzed according to urinary symptoms, tumor aggressiveness and tumor extension. Variations in melatonin levels were estimated using generalized estimating equations on the ln-transformed values. To estimate the association between amplitude, acrophase and PCa, adjusted odds ratio (aOR) and 95% CI were calculated using logistic regression models. RESULTS: The mean age was 67.0 years (SD 7.3) for cases and 67.5 (SD 5.5) for controls. Melatonin levels were always lower in PCa cases than in controls. On average, melatonin levels in cases were -64.0% (95% CI -73.4, -51.4) than controls. PCa cases had lower amplitude, 26.0 pg/ml (SD 27.8) vs 46.3 pg/ml (SD 28.2; p <0.001). A high amplitude was associated with a decreased risk of PCa, aOR=0.31 (95% CI 0.11, 0.86), while a late acrophase could be increased risk of PCa, aOR=2.36 (95% CI 0.88, 6.27). CONCLUSIONS: Patients with PCa always had lower melatonin levels than men without PCa, independent of urinary symptomatology or extension and aggressiveness of the tumor.
引用
- Lozano-Lorca M, Olmedo-Requena R, Rodríguez-Barranco M, et al. Salivary Melatonin Rhythm and Prostate Cancer: CAPLIFE Study. J Urol. 2021. PMID: 34694161. doi:10.1097/JU.0000000000002294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。